Sort by: after hours percent change | delayed percent change | gain open | gain high | gain close | publishing date
tags : Phase 2 save search
MediWound Announces Last Patient Out in EscharEx U.S. Phase 2 Trial for the Debridement of Chronic Wounds
Published: 2022-03-21 (Crawled : 13:30) - biospace.com/
MDWD | $1.82 5.81% 3.3% |
|
Health Technology
|
| O: 2.04%
H: 0.5%
C: -3.5%
phase 2 ces trial
Athira Pharma Presents Study Overview and Baseline Data from ACT-AD Phase 2 Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease at the 2022 AD/PD™ Congress
Published: 2022-03-20 (Crawled : 12:20) - globenewswire.com
ATHA S | $2.79 -2.11% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
alzheimer phase 2 trial disease alzheimer’s alzheimer's disease alzheimer's act-ad phase 2
PICCOLO: A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent, Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor Alpha Expression
Published: 2022-03-19 (Crawled : 00:20) - immunogen.com
IMGN | $4.29 -2.28% -0.23% |
|
Health Technology
| Email alert
Add to watchlist
phase 2 one cancer mirvetuximab
Recursion Announces Enrollment of First Patient in Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation
Published: 2022-03-18 (Crawled : 12:30) - biospace.com/
RXRX 4 | $8.08 -2.06% -0.25% |
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 7.95%
C: 3.61%
treatment phase 2 ces trial enroll rec-994
Ionis announces publication of positive Phase 2 data for donidalorsen in New England Journal of Medicine
Published: 2022-03-16 (Crawled : 00:00) - prnewswire.com
IONS | $37.97 -3.48% 0.0% |
|
Health Technology
|
| O: -0.15%
H: 2.62%
C: 2.45%
phase 2 pos positive
Oramed Completes Patient Enrollment in Phase 2 Oral Insulin NASH Trial
Published: 2022-03-16 (Crawled : 13:00) - biospace.com/
ORMP | $4.56 0.89% 0.0% |
|
Health Technology
|
| O: 2.48%
H: 4.79%
C: 4.29%
phase 2 trial enroll insulin nash
Ocuphire Completes Enrollment of Over 100 Subjects in 24-Week ZETA-1 Phase 2b Trial of Oral APX3330 for the Treatment of Diabetic Retinopathy
Published: 2022-03-16 (Crawled : 12:00) - globenewswire.com
OCUP | $1.96 -2.49% 0.0% |
|
Health Technology
|
| O: 0.6%
H: 3.28%
C: 0.9%
apx3330 treatment phase 2 phase 2b trial 100 diabetic enroll diabetes
Protagonist Therapeutics Earns $25 Million Milestone Payment from Janssen Biotech for Dosing of Third Patient in Phase 2b Clinical Trial of PN-235 in Moderate-to-Severe Plaque Psoriasis
Published: 2022-03-16 (Crawled : 12:00) - biospace.com/
PTGX | $8.45 -7.35% -3.55% |
|
Health Technology
|
| O: 2.01%
H: 1.1%
C: 0.57%
pn-235 phase 2 phase 2b trial therapeutics psoriasis one biotech iot milestone
U.K. Competition and Markets Authority to Refer Merger to a Phase 2 Review
Published: 2022-03-16 (Crawled : 08:00) - prnewswire.com
NLOK | $22.27 -1.85% -2.92% |
|
Technology Services
|
| O: -3.39%
H: 0.69%
C: -10.24%
phase 2 merge
Windtree Completes Enrollment of Phase 2 Study of Istaroxime in Early Cardiogenic ShockOn track for top-line data in April 2022
Published: 2022-03-15 (Crawled : 20:00) - biospace.com/
WINT | $0.43 -3.2% -1.37% |
|
Health Technology
|
| O: 2.07%
H: 4.17%
C: -0.52%
phase 2 top-line data cardio star enroll topline
Revelation Biosciences Inc. Announces Enrollment and Dosing Complete for Phase 2b Viral Challenge Study to Assess Efficacy of Intranasal REVTx 99 for the Prevention of H3N2 Influenza Infection
Published: 2022-03-15 (Crawled : 13:30) - biospace.com/
REVB | $0.4925 -0.51% -2.52% |
|
|
| O: 9.8%
H: 63.39%
C: 11.61%
phase 2 phase 2b bioscience infection influenza enroll infections
MAIA Biotechnology, Inc. Announces HREC Approval in Australia for its THIO-101 Phase 2 Trial for NSCLC
Published: 2022-03-15 (Crawled : 13:30) - biospace.com/
SNYNF | News | $108.84 4.15% |
|
Health Technology
|
| O: -3.03%
H: 3.21%
C: 3.21%
SNY | News | $52.14 -0.88% -0.38% |
|
Health Technology
|
| O: 3.07%
H: 0.0%
C: 0.0%
thio-101 phase 2 technology trial approval australia biotech iot
Alector Presents AL001 (latozinemab) Data from the FTD-C9orf72 Cohort of the INFRONT-2 Phase 2 Clinical Trial
Published: 2022-03-15 (Crawled : 12:30) - globenewswire.com
ALEC A | $10.11 -5.87% -9.0% |
|
Health Technology
|
| O: 1.85%
H: 1.38%
C: -5.38%
al001 ema phase 2 trial
Arrowhead Files for Regulatory Clearance to Initiate Phase 1/2a Study of ARO-RAGE for Treatment of Asthma
Published: 2022-03-15 (Crawled : 12:30) - biospace.com/
ARWR | $32.47 -3.71% -0.8% |
|
Health Technology
|
| O: 1.89%
H: 2.65%
C: 0.87%
treatment clearance phase 1 phase 2
Trevi Therapeutics Concludes Enrollment for Phase 2 CANAL Trial in IPF Chronic Cough
Published: 2022-03-15 (Crawled : 12:00) - prnewswire.com
TRVI A | $2.02 1.0% 2.97% |
|
Health Technology
|
| O: 2.27%
H: 14.07%
C: 8.15%
phase 2 trial therapeutics chronic cough enroll
Anavex Life Sciences Announces Presentation of Phase 2 Clinical Biomarker Data from ANAVEX®2-73-PDD-001 Parkinson’s Disease Dementia Study at AD/PD™ 2022 International Conference
Published: 2022-03-15 (Crawled : 12:00) - biospace.com/
AVXL | $9.91 -1.78% 0.0% |
|
Health Technology
|
| O: 0.4%
H: 6.32%
C: 5.24%
pdd-001 anavex phase 2 dementia anavex®2-73 parkinson conference presentation disease life science international tiona
Sage Therapeutics Announces Presentation of Encouraging Results from the Phase 2 PARADIGM Study (Part A) of SAGE-718 in Patients with Mild Cognitive Impairment due to Parkinson’s Disease
Published: 2022-03-15 (Crawled : 12:00) - biospace.com/
SAGE | $32.54 -6.84% 4.98% |
|
Health Technology
|
| O: 1.07%
H: 2.93%
C: 1.06%
sage-718 phase 2 air parkinson therapeutics presentation disease results
PDS Biotech Announces Achievement of an Enrollment Objective in National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based Combination in Advanced HPV-Associated Cancers
Published: 2022-03-15 (Crawled : 12:00) - globenewswire.com
PDSB | $3.9 -0.76% 2.05% |
|
Health Technology
|
| O: 0.2%
H: 7.86%
C: 7.27%
pds0101 phase 2 ces hpv trial cancer biotech iot tiona enroll
IDEAYA Biosciences Reports IDE397 Interim Phase 1 Clinical Data
Published: 2022-03-15 (Crawled : 12:00) - biospace.com/
IDYA | News | $13.09 -3.82% -7.95% |
|
Health Technology
|
| O: -6.99%
H: 9.17%
C: -1.74%
ide397 idea phase 1 report bioscience phase 2 phase 3
AnaptysBio Reports Imsidolimab ACORN Phase 2 Clinical Trial Data in Moderate-to-Severe Acne
Published: 2022-03-14 (Crawled : 22:00) - biospace.com/
ANAB A | $20.8 -7.64% 1.92% |
|
Health Technology
|
| O: 0.31%
H: 2.23%
C: -0.97%
phase 2 trial acne report
Your saved searches
Save your searches and get alerts when important news are released.
Mentioned Today
ABB | News | $26.87 -0.85% 0.48% |
|
Producer Manufacturing
ABLZF | News | $28.0 1.08% |
|
Producer Manufacturing
ACN | News | $283.8 -3.01% -1.34% |
|
Technology Services
AIH | News | $1.95 0.52% -2.05% |
|
Health Services
AKAM | News | $92.39 -2.25% 0.5% |
|
Technology Services
ALPMF | News | $16.71 5.56% |
|
Health Technology
ALPMY | News | $16.14 1.19% |
|
Manufacturing
APH | News | $64.72 -2.12% 0.0% |
|
Electronic Technology
ARVL | News | $1.61 -4.73% 0.0% |
|
Manufacturing
AUOTY | News | $6.01 1.01% |
|
Manufacturing
AVAV | News | $81.71 -1.35% -10.66% |
|
Electronic Technology
AXON | News | $95.0 -1.85% 3.39% |
|
Manufacturing
BHC | News 4 | $8.83 1.73% -0.57% |
|
Health Technology
BNPQF | News | $49.65 -4.65% |
|
Finance
BNPQY | News | $24.99 -0.99% |
|
Finance and Insurance
BNPZY | News | $ 0% |
|
Finance and Insurance
BTG | News | $3.55 -3.01% 1.13% |
|
Non-Energy Minerals
CERN | News | $94.92 0.03% |
|
Technology Services
CGNT | News | $4.58 -28.66% 2.4% |
|
CGNX | News | $44.63 -1.85% -2.31% |
|
Electronic Technology
CLH | News | $87.8 0.92% 0.0% |
|
Industrial Services
CNF | News | $3.21 -4.46% 0.0% |
|
Finance
COLD | News | $30.06 -0.76% 0.0% |
|
Finance
COP | News | $95.22 3.24% -0.2% |
|
Energy Minerals
CRCW | News | $0.965 1.58% |
|
Information
CREE | News | $80.07 0% |
|
Electronic Technology
CRM | News 4 | $171.46 -5.43% -0.31% |
|
Technology Services
CSCO | News | $43.06 -1.62% 0.09% |
|
Technology Services
CTXS | News | $96.15 -0.63% 0.0% |
|
Technology Services
CVLT | News | $63.29 -2.78% 0.0% |
|
Technology Services
CW | News | $131.15 -0.67% 0.0% |
|
Electronic Technology
DELL | News | $48.94 -2.59% 0.0% |
|
Electronic Technology
DGII | News | $23.3 -4.04% 0.0% |
|
Electronic Technology
DHR | News | $251.88 -1.77% 0.34% |
|
Health Technology
DKILF | News | $157.75 -5.18% |
|
Producer Manufacturing
DKILY | News | $16.18 0.81% |
|
Manufacturing
ECOM | News | $14.68 1.17% 4.97% |
|
Technology Services
ERIC | News | $7.78 -2.14% -0.39% |
|
Electronic Technology
ESLT | News | $210.38 1.14% 0.0% |
|
Electronic Technology
ETNB | News 0 d | $3.55 3.2% -4.79% |
|
Health Technology
EVH | News | $30.94 -2.74% 0.0% |
|
Commercial Services
FANH | News | $5.15 -1.91% 1.17% |
|
Finance
FCN | News | $172.21 -1.22% 0.0% |
|
Commercial Services
FLIR | News | $57.34 0% |
|
Electronic Technology
GBERF | News | $546.0 |
|
Producer Manufacturing
GBERY | News | $48.7 -1.6% |
|
Manufacturing
GE | News | $65.88 -1.24% -0.47% |
|
Electronic Technology
GLAXF | News | $21.99 4.22% |
|
Health Technology
GLPI | News 0 d | $46.68 -0.09% -3.06% |
|
Finance
GSK | News | $43.35 -0.8% -0.37% |
|
Health Technology
GXO | News | $45.5 -1.22% 2.13% |
|
HLF | News | $22.86 -2.52% 0.0% |
|
Distribution Services
HNI | News | $35.65 -2.33% 0.0% |
|
Producer Manufacturing
HON | News | $175.95 -1.31% 0.03% |
|
Producer Manufacturing
HY | News | $33.35 -3.42% 0.0% |
|
Producer Manufacturing
IKTSF | News | $59.175 |
|
Commercial Services
IKTSY | News | $53.97 0.26% |
|
Professional, Scientific, and T...
INCY | News | $75.63 -2.24% -0.99% |
|
Health Technology
INTU | News 4 | $386.29 -4.55% 0.0% |
|
Technology Services
IRCP | News | $2.4984 0.06% |
|
Finance
JCI | News | $48.44 -0.43% 0.0% |
|
Producer Manufacturing
JG | News | $1.09 -0.91% -0.92% |
|
Technology Services
JTEKF | News | $ 0% |
|
Producer Manufacturing
JTEKY | News | $24.29 |
|
Manufacturing
LEA | News | $134.75 0.57% 0.0% |
|
Producer Manufacturing
LHX | News | $235.82 -0.42% 0.0% |
|
Electronic Technology
LII | News | $202.46 -0.42% 0.0% |
|
Producer Manufacturing
LLY | News 4 | $317.62 -2.95% -0.26% |
|
Health Technology
LMT | News | $420.71 0.35% 0.21% |
|
Electronic Technology
MASI | News | $137.07 -1.95% 0.0% |
|
Health Technology
MCFUF | News | $4.105 |
|
Technology Services
MCK | News 4 | $321.55 -1.44% -0.02% |
|
Distribution Services
MDRX | News 4 | $15.33 -2.23% 0.0% |
|
Technology Services
MDT | News | $89.2 -1.4% 0.34% |
|
Health Technology
MSFT | News | $256.48 -3.18% 0.06% |
|
Technology Services
MSI | News | $210.24 -3.17% 1.42% |
|
Electronic Technology
MTX | News | $61.47 -0.87% 0.0% |
|
Process Industries
NAT | News | $2.21 -0.9% -0.45% |
|
Transportation
NDAQ | News 4 | $154.66 -2.07% -1.61% |
|
Finance
NIO | News | $22.36 -2.57% -7.25% |
|
Consumer Durables
NIPNF | News | $38.0 |
|
Technology Services
NOC | News | $464.67 -0.46% 0.74% |
|
Electronic Technology
NOK | News | $4.75 -1.45% 0.63% |
|
Electronic Technology
NOKBF | News | $4.954 0.41% |
|
Electronic Technology
NUAN | News | $55.99 0% |
|
Technology Services
NUVB | News | $3.55 -2.47% 2.82% |
|
NVS | News | $84.17 -1.3% -0.18% |
|
Health Technology
NVSEF | News | $84.85 1.0% |
|
Health Technology
ORCL | News 4 | $68.58 -2.6% 1.04% |
|
Technology Services
PCRFF | News | $8.217 0.82% |
|
n/a
PCRFY | News | $8.16 -0.73% |
|
n/a
PHI | News | $31.73 1.47% 0.0% |
|
Communications
PHTCF | News | $30.23 -17.81% |
|
Communications
PPRUF | News | $544.41 1.95% |
|
Consumer Non-Durables
PPRUY | News | $52.31 0.13% |
|
Manufacturing
RELX | News | $26.77 -1.91% -0.45% |
|
Commercial Services
RLXXF | News | $26.94 -1.93% |
|
Commercial Services
RNGR | News | $10.28 -0.48% 0.0% |
|
Industrial Services
ROK | News | $197.64 -1.82% 0.0% |
|
Producer Manufacturing
RSG | News 4 | $127.91 -1.15% 0.0% |
|
Industrial Services
RYLPF | News | $21.425 -2.83% |
|
Health Technology
SAP | News | $95.47 -1.88% -1.26% |
|
Technology Services
SAPGF | News | $97.382 -1.0% |
|
Technology Services
SBGSF | News | $124.59 -1.9% |
|
Producer Manufacturing
SBGSY | News | $24.426 -0.99% |
|
Manufacturing
SEKEF | News | $15.184 -6.47% |
|
Electronic Technology
SEKEY | News | $7.34 -0.74% |
|
Manufacturing
SNNUF | News | $15.05 4.44% |
|
Health Technology
TEL | News | $114.92 -2.24% 0.0% |
|
Electronic Technology
TEVJF | News | $8.34 0.48% |
|
Health Technology
TMO | News | $535.77 -1.45% -1.84% |
|
Health Technology
TRI | News | $101.23 -2.95% 0.0% |
|
Commercial Services
TXT | News | $60.05 -1.22% 0.0% |
|
Electronic Technology
UL | News | $45.33 -1.46% -0.13% |
|
Consumer Non-Durables
UNLYF | News | $45.805 -3.0% |
|
Consumer Non-Durables
VEON | News | $0.4567 -0.74% 0.42% |
|
Communications
VMW | News | $116.25 -1.2% 0.0% |
|
Technology Services
VSH | News | $18.22 -0.92% 0.0% |
|
Electronic Technology
VTRS | News | $10.9 -1.54% 1.19% |
|
Health Technology
VUZI | News | $6.85 2.39% 2.19% |
|
Electronic Technology
WFC | News 4 | $40.18 -0.15% -0.08% |
|
Finance
WKEY | News | $2.68 -5.63% 2.24% |
|
Technology Services
WM | News | $148.88 -0.43% 0.42% |
|
Industrial Services
XYL | News 4 | $77.9 -2.07% 0.0% |
|
Producer Manufacturing
ZIXI | News | $8.48 0% |
|
Technology Services
ZTS | News 4 | $170.12 -2.01% 0.0% |
|
Health Technology
ZUO | News 4 | $9.3 -5.3% 0.0% |
|
Technology Services